Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kris Huygen

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
Infection and Immunity|January 24, 2006
Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing Mycobacterial antigen 85A and Mycobacterium bovis BCGH Martin Vordermeier, Kris Huygen, Mahavir Singh, et al.
Mycopathologia|November 24, 2016
Development of a Dot-Blot Assay for the Detection of Mould-Specific IgE in the Belgian PopulationMuriel Vincent, Marta Romano, Francis Corazza, et al.
Vaccine|July 19, 2015
Humoral and cell mediated immune responses to a pertussis containing vaccine in pregnant and nonpregnant womenKris Huygen, Raïssa Nadège Caboré, Kirsten Maertens, et al.
Infection and Immunity|March 21, 2012
Mycobacterium tuberculosis lacking all mycolic acid cyclopropanation is viable but highly attenuated and hyperinflammatory in miceDaniel Barkan, Dorsaf Hedhli, Han-Guang Yan, et al.
Immunology|June 1, 2013
Mice genetically inactivated in interleukin-17A receptor are defective in long-term control of Mycobacterium tuberculosis infectionDanielle Freches, Hannelie Korf, Olivier Denis, et al.
Clinical and Vaccine Immunology : CVI|January 29, 2010
Validation of a medium-throughput method for evaluation of intracellular growth of Mycobacterium tuberculosisDaniel Eklund, Amanda Welin, Thomas Schön, et al.
Vaccines|September 8, 2015
Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety ConsiderationsAmaya Leunda, Aline Baldo, Martine Goossens, et al.
Immunology Letters|June 16, 2007
Mucosal prime-boost vaccination for tuberculosis based on TLR triggering OprI lipoprotein from Pseudomonas aeruginosa fused to mycolyl-transferase Ag85ATatiana Gartner, Martijn Baeten, Samuel Otieno, et al.
Plos One|October 23, 2013
M.tuberculosis mutants lacking oxygenated mycolates show increased immunogenicity and protective efficacy as compared to M. bovis BCG vaccine in an experimental mouse modelDorsaf Hedhli, Olivier Denis, Daniel Barkan, et al.
Vaccine|April 28, 2005
DNA vaccination for the priming of neutralizing antibodies against non-immunogenic STa enterotoxin from enterotoxigenic Escherichia coliNadia Ruth, Jacques Mainil, Virginie Roupie, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Infection and Immunity|January 24, 2006
Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing Mycobacterial antigen 85A and Mycobacterium bovis BCGH Martin Vordermeier, Kris Huygen, Mahavir Singh, et al.
Mycopathologia|November 24, 2016
Development of a Dot-Blot Assay for the Detection of Mould-Specific IgE in the Belgian PopulationMuriel Vincent, Marta Romano, Francis Corazza, et al.
Vaccine|July 19, 2015
Humoral and cell mediated immune responses to a pertussis containing vaccine in pregnant and nonpregnant womenKris Huygen, Raïssa Nadège Caboré, Kirsten Maertens, et al.
Infection and Immunity|March 21, 2012
Mycobacterium tuberculosis lacking all mycolic acid cyclopropanation is viable but highly attenuated and hyperinflammatory in miceDaniel Barkan, Dorsaf Hedhli, Han-Guang Yan, et al.
Immunology|June 1, 2013
Mice genetically inactivated in interleukin-17A receptor are defective in long-term control of Mycobacterium tuberculosis infectionDanielle Freches, Hannelie Korf, Olivier Denis, et al.
Clinical and Vaccine Immunology : CVI|January 29, 2010
Validation of a medium-throughput method for evaluation of intracellular growth of Mycobacterium tuberculosisDaniel Eklund, Amanda Welin, Thomas Schön, et al.
Vaccines|September 8, 2015
Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety ConsiderationsAmaya Leunda, Aline Baldo, Martine Goossens, et al.
Immunology Letters|June 16, 2007
Mucosal prime-boost vaccination for tuberculosis based on TLR triggering OprI lipoprotein from Pseudomonas aeruginosa fused to mycolyl-transferase Ag85ATatiana Gartner, Martijn Baeten, Samuel Otieno, et al.
Plos One|October 23, 2013
M.tuberculosis mutants lacking oxygenated mycolates show increased immunogenicity and protective efficacy as compared to M. bovis BCG vaccine in an experimental mouse modelDorsaf Hedhli, Olivier Denis, Daniel Barkan, et al.
Vaccine|April 28, 2005
DNA vaccination for the priming of neutralizing antibodies against non-immunogenic STa enterotoxin from enterotoxigenic Escherichia coliNadia Ruth, Jacques Mainil, Virginie Roupie, et al.
Pageof 11